<DOC>
	<DOCNO>NCT02960763</DOCNO>
	<brief_summary>The purpose research study ass antidepressant work best old adult treatment-resistant depression .</brief_summary>
	<brief_title>Optimizing Outcomes Treatment-Resistant Depression Older Adults</brief_title>
	<detailed_description>Older adult participant treatment-resistant depression randomly assign Step 1 medication strategy . - Adding aripiprazole current antidepressant medication - Adding bupropion current antidepressant medication - Replacing current antidepressant medication bupropion If depression relieve end 10 week , participant randomly assign Step 2 medication strategy : - Adding lithium current antidepressant medication - Replacing current antidepressant medication nortriptyline All medication strategy offer collaboration participant ' physician research team provide support guidance . If depression relieve Step 1 2 , participant enter Continuation Phase ass long term follow-up outcome 12 month .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Men woman age 60 old Current Major Depressive Disorder ( MDD ) Failure respond adequately two antidepressant treatment trial recommend dose length ( least 12 week ) Patient Health Questionnaire9 ( PHQ9 ) score 6 high Inability provide inform consent Dementia Lifetime diagnosis bipolar I II disorder , schizophrenia , schizoaffective disorder , schizophreniform disorder , delusional disorder , current psychotic symptom High risk suicide unable manage safely clinical trial Contraindication propose study medication , determine study physician include history intolerance nonresponse propose medication . Noncorrectable , clinically significant sensory impairment interfere participation Unstable medical illness , include delirium , uncontrolled diabetes mellitus , hypertension , hyperlipidemia , cerebrovascular cardiovascular risk factor medical management . Moderate severe substance alcohol use disorder</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Comparative Effectiveness Research</keyword>
	<keyword>Pragmatic Clinical Trials</keyword>
	<keyword>Patient-Centered Outcomes Research</keyword>
</DOC>